Usefulness of Pep-Test for Laryngo-Pharyngeal Reflux: A Pilot Study in Primary Care

다국어 초록 (Multilingual Abstract)

Background: Gastroesophageal reflux disease is a digestive disorder characterized by nausea, regurgitation, and heartburn. Gastroesophageal reflux is the primary cause of laryngeal symptoms, especially chronic posterior laryngitis.
The best diagnostic test for this disease is esophageal impedance-pH monitoring; however, it is poorly employed owing to its high cost and invasiveness. Salivary pepsin measured using a lateral flow device (Pep-test) has been suggested as an indirect marker of laryngopharyngeal reflux (LPR). The present study tested the reliability of Pep-test in diagnosing LPR in uninvestigated primary care attenders presenting with chronic laryngeal symptoms, and evaluated the raw pepsin concentration in patients with LPR.
Methods: A multicenter, non-interventional pilot study was conducted on 86 suspected patients with LPR and 59 asymptomatic subjects as controls in three Italian primary care settings. A reflux symptom index questionnaire was used to differentiate patients with LPR (score >13) from controls (score <5). Two saliva samples were collected, and comparisons between the groups were performed using two-sided statistical tests, according to variable distributions.
Results: There was no statistical difference in the salivary pepsin positivity between LPR patients and controls, whereas the pepsin intensity value was higher in controls than in LPR patients.
Conclusion: A high prevalence of pepsin positivity was observed in asymptomatic controls. Pepsin measurement should not be considered as a diagnostic test for LPR in primary care patients.

참고문헌 (Reference)

1 Belafsky PC, "Validity and reliability of the re-flux symptom index(RSI)" 16 : 274-277, 2002

2 De Bortoli N, "Use of a non-invasive pepsin diagnostic test to detect GERD : correlation with MII-pH evaluation in a series of suspected NERD patients : a pilot study" 45 (45): S68-S69, 2013

3 Koufman JA, "The otolaryngologic manifestations of gastroesophageal reflux disease(GERD) : a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury" 101 (101): 1-78, 1991

4 Jones R, "The gastro-oesophageal reflux disease impact scale : a patient management tool for primary care" 25 : 1451-1459, 2007

5 Lagergren J, "Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma" 340 : 825-831, 1999

6 Knight J, "Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux" 115 : 1473-1478, 2005

7 Bardhan KD, "Reflux revisited : advancing the role of pepsin" 2012 : 646901-, 2012

8 Saritas Yuksel E, "Rapid salivary pepsin test : blinded assessment of test performance in gastroesophageal reflux disease" 122 : 1312-1316, 2012

9 Lowden M, "Prevalence of symptoms suggestive of extra-oesophageal reflux in a general practice population in the UK" 34 : 32-35, 2009

10 Hayat JO, "Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease" 64 : 373-380, 2015

11 Kim TH, "Pepsin detection in the sputum/saliva for the diagnosis of gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal reflux disease symptoms" 77 : 201-206, 2008

12 Gatta L, "Meta-analysis : the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease" 25 : 385-392, 2007

13 Stein DJ, "Incidence of chronic laryngitis" 122 : 771-774, 2013

14 Katz PO, "Guidelines for the diagnosis and management of gastroesophageal reflux disease" 108 : 308-328, 2013

15 Wilson JA, "Gastroesophageal reflux and posterior laryngitis" 98 : 405-410, 1989

16 Gurski RR, "Extraesophageal manifestations of gastroesophageal reflux disease" 32 : 150-160, 2006

17 Savarino E, "Expert consensus document : advances in the physiological assessment and diagnosis of GERD" 14 : 665-676, 2017

18 Wong RK, "ENT manifestations of gastroesophageal reflux" 95 (95): S15-S22, 2000

19 Strugala V, "Detection of pepsin in sputum : a rapid and objective measure of airways reflux" 47 : 339-341, 2016

20 Wang L, "Correlation of pepsin-measured laryngopharyngeal reflux disease with symptoms and signs" 143 : 765-771, 2010

21 Potluri S, "Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx, and lung" 48 : 1813-1817, 2003

22 Gelardi M, "Clinical-diagnostic correlations in laryngopharyngeal reflux(LPR) : the role of Peptest" 1 : 1-8, 2017

23 Jaspersen D, "Clinical course of laryngo-respiratory symptoms in gastro-oesophageal reflux disease during routine care : a 5-year follow-up" 29 : 1172-1178, 2009

24 Dettmar PW, "Chronic pharyngitis and the association with pepsin detection and reflux disease" 1 : 17-, 2018

25 Savarino E, "Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease : study using combined impedance-pH off therapy" 105 : 1053-1061, 2010

26 Roman S, "Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease : update of the Porto consensus and recommendations from an international consensus group" 29 : 1-15, 2017

27 Collen MJ, "Age does not affect basal gastric acid secretion in normal subjects or in patients with acid-peptic disease" 89 : 712-716, 1994

28 Yadlapati R, "Abilities of oropharyngeal pH tests and salivary pepsin analysis to discriminate between asymptomatic volunteers and subjects with symptoms of laryngeal irritation" 14 : 535-542, 2016